Institutions / VR Adviser, LLC
VR Adviser, LLC
CIK 1615982 · Institution · as of Dec 31, 2025
Portfolio value
$2.02B
Positions
27
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 27 →
| Company | Value | % of portfolio |
|---|---|---|
| Apogee Therapeutics, Inc. | $641.08M | 31.7% |
| Oruka Therapeutics, Inc. | $125.74M | 6.2% |
| Viridian Therapeutics, Inc. | $120.83M | 6.0% |
| Spyre Therapeutics, Inc. | $120.74M | 6.0% |
| KalVista Pharmaceuticals Inc | $108.67M | 5.4% |
| Ocular Therapeutix, Inc | $88.81M | 4.4% |
| Savara IncSVRA | $82.85M | 4.1% |
| Cogent Biosciences, Inc. | $71.04M | 3.5% |
| Erasca, Inc.ERAS | $66.43M | 3.3% |
| CytomX Therapeutics, Inc. | $66.29M | 3.3% |
| Maze Therapeutics, Inc. | $64.16M | 3.2% |
| Jade Biosciences, Inc. | $49.69M | 2.5% |
| Enliven Therapeutics, Inc.ELVN | $49.69M | 2.5% |
| Oric Pharmaceuticals, Inc. | $46.43M | 2.3% |
| enGene Therapeutics Inc. | $43.09M | 2.1% |
| Dyne Therapeutics, Inc. | $42.52M | 2.1% |
| Dianthus Therapeutics, Inc. | $41.21M | 2.0% |
| Upstream Bio, Inc.UPB | $31.75M | 1.6% |
| Cybin Inc. | $31.41M | 1.6% |
| Zura Bio Limited | $28.01M | 1.4% |
| Vor Biopharma Inc. | $25.42M | 1.3% |
| Crescent Biopharma, Inc. | $25.30M | 1.2% |
| Septerna, Inc.SEPN | $17.03M | 0.8% |
| Surrozen, Inc./DESRZN | $14.30M | 0.7% |
| Cullinan Therapeutics, Inc. | $14.28M | 0.7% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.